Inspirion Wealth Advisors LLC Has $606,000 Stock Position in CME Group Inc. (NASDAQ:CME)

Inspirion Wealth Advisors LLC raised its position in shares of CME Group Inc. (NASDAQ:CME) by 2.7% in the second quarter, HoldingsChannel.com reports. The firm owned 3,080 shares of the financial services provider’s stock after purchasing an additional 80 shares during the quarter. Inspirion Wealth Advisors LLC’s holdings in CME Group were worth $606,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in CME. Vanguard Group Inc. lifted its stake in CME Group by 0.6% in the fourth quarter. Vanguard Group Inc. now owns 33,451,194 shares of the financial services provider’s stock valued at $7,044,821,000 after buying an additional 215,044 shares during the period. Capital International Investors grew its holdings in CME Group by 24.1% in the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock worth $3,403,557,000 after purchasing an additional 3,069,806 shares during the period. Capital World Investors increased its stake in CME Group by 8.7% in the fourth quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock valued at $3,072,654,000 after purchasing an additional 1,172,575 shares in the last quarter. Bank of New York Mellon Corp raised its holdings in shares of CME Group by 2.9% during the first quarter. Bank of New York Mellon Corp now owns 6,793,988 shares of the financial services provider’s stock valued at $1,462,678,000 after purchasing an additional 189,842 shares during the period. Finally, Parnassus Investments LLC boosted its position in shares of CME Group by 0.4% during the 4th quarter. Parnassus Investments LLC now owns 5,667,384 shares of the financial services provider’s stock worth $1,193,551,000 after purchasing an additional 23,583 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Up 0.7 %

Shares of CME stock traded up $1.51 on Friday, hitting $206.66. The stock had a trading volume of 1,011,306 shares, compared to its average volume of 1,974,399. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.01. The business has a 50 day moving average of $197.97 and a 200 day moving average of $207.00. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $223.80. The stock has a market cap of $74.41 billion, a price-to-earnings ratio of 23.51, a price-to-earnings-growth ratio of 6.27 and a beta of 0.52.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.53 by $0.03. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The business had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.53 billion. During the same period in the prior year, the firm posted $2.30 EPS. The firm’s quarterly revenue was up 12.7% compared to the same quarter last year. As a group, analysts expect that CME Group Inc. will post 9.8 EPS for the current year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Monday, September 9th will be given a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.23%. The ex-dividend date of this dividend is Monday, September 9th. CME Group’s payout ratio is 52.33%.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the company. Piper Sandler dropped their price target on CME Group from $235.00 to $225.00 and set an “overweight” rating on the stock in a research note on Thursday, July 25th. Keefe, Bruyette & Woods upped their target price on CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research report on Thursday, July 25th. JPMorgan Chase & Co. lifted their price target on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research report on Thursday, July 25th. Bank of America upped their price objective on shares of CME Group from $209.00 to $216.00 and gave the stock a “neutral” rating in a report on Thursday, April 25th. Finally, Rosenblatt Securities reiterated a “sell” rating and set a $187.00 price objective (up from $185.00) on shares of CME Group in a report on Thursday, April 25th. Three investment analysts have rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $212.64.

Insider Buying and Selling

In other news, Director Charles P. Carey sold 3,000 shares of CME Group stock in a transaction on Thursday, June 13th. The stock was sold at an average price of $195.44, for a total transaction of $586,320.00. Following the sale, the director now directly owns 7,163 shares in the company, valued at approximately $1,399,936.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, Director Charles P. Carey sold 3,000 shares of the stock in a transaction that occurred on Thursday, June 13th. The shares were sold at an average price of $195.44, for a total transaction of $586,320.00. Following the completion of the transaction, the director now directly owns 7,163 shares of the company’s stock, valued at approximately $1,399,936.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Elizabeth A. Cook sold 1,000 shares of CME Group stock in a transaction that occurred on Monday, May 20th. The stock was sold at an average price of $211.52, for a total transaction of $211,520.00. Following the completion of the sale, the director now directly owns 18,241 shares in the company, valued at approximately $3,858,336.32. The disclosure for this sale can be found here. Over the last three months, insiders have sold 7,150 shares of company stock worth $1,455,401. 0.30% of the stock is owned by company insiders.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.